Relypsa Receives $2,587,888 New Funding Round

  • Feed Type
  • Date
    12/11/2012
  • Company Name
    Relypsa
  • Mailing Address
    5301 Patrick Henry Drive Santa Clara, CA 95054
  • Company Description
    Relypsa, Inc. is a biopharmaceutical company leading the discovery and development of new non-absorbed polymeric drugs for important applications in renal and cardiovascular disease.
  • Website
    http://www.relypsa.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,587,888
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.